Cargando…
Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865512/ https://www.ncbi.nlm.nih.gov/pubmed/27242489 http://dx.doi.org/10.3389/fnhum.2016.00226 |
| _version_ | 1782431793063919616 |
|---|---|
| author | Koudriavtseva, Tatiana Mainero, Caterina |
| author_facet | Koudriavtseva, Tatiana Mainero, Caterina |
| author_sort | Koudriavtseva, Tatiana |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4865512 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-48655122016-05-30 Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation Koudriavtseva, Tatiana Mainero, Caterina Front Hum Neurosci Neuroscience Frontiers Media S.A. 2016-05-13 /pmc/articles/PMC4865512/ /pubmed/27242489 http://dx.doi.org/10.3389/fnhum.2016.00226 Text en Copyright © 2016 Koudriavtseva and Mainero. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Neuroscience Koudriavtseva, Tatiana Mainero, Caterina Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation |
| title | Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation |
| title_full | Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation |
| title_fullStr | Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation |
| title_full_unstemmed | Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation |
| title_short | Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation |
| title_sort | brain atrophy as a measure of neuroprotective drug effects in multiple sclerosis: influence of inflammation |
| topic | Neuroscience |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865512/ https://www.ncbi.nlm.nih.gov/pubmed/27242489 http://dx.doi.org/10.3389/fnhum.2016.00226 |
| work_keys_str_mv | AT koudriavtsevatatiana brainatrophyasameasureofneuroprotectivedrugeffectsinmultiplesclerosisinfluenceofinflammation AT mainerocaterina brainatrophyasameasureofneuroprotectivedrugeffectsinmultiplesclerosisinfluenceofinflammation |